Vaccine preparation comprising a bacterial toxin adjuvant

Details Vaccine preparation comprising a bacterial toxin adjuvant Vaccine preparation comprising a bacterial toxin adjuvant

A - Human Necessities

61

K

167/129, 167/135

A61K 39/39 (2006.01) A61K 39/00 (2006.01)

Patent

CA 1335571

A vaccine preparation comprising in combination vaccine and a toxin or subunit thereof as an effective component. The toxin is preferably a bacterial toxin, e.g., cholera toxin, staphylococcal .alpha.-hemolysin, staphylococcal .delta.-hemolysin, vibrio thermostable direct hemolysin, pertussis toxin or E. coli heat-labile toxin. The toxin can be a B subunit or a part of a B subunit of a toxin. The vaccine can be influenza vaccine, pertussis vaccine, Japanese encephalitis vaccine, mixed vaccine or pertussis, diphtheria and tetanus toxoid, hepatitis B vaccine, rota vaccine, measles vaccine, rubella vaccine, mumps vaccine, combined vaccine of measles, rubella and mumps, or mycoplasma vaccine. The ratio of vaccine to toxin or subunit thereof is 1:0.0001-1:10,000 (w/v). The vaccine can be intranasal vaccine, or can be in injectable form, spray form or oral administration form.

596019

Affiliated with

Also associated with

Rating

Vaccine preparation comprising a bacterial toxin adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine preparation comprising a bacterial toxin adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine preparation comprising a bacterial toxin adjuvant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1253201